A study protocol for Project I-Test: a cluster randomized controlled trial of a practice coaching intervention to increase HIV testing in substance use treatment programs.
| العنوان: | A study protocol for Project I-Test: a cluster randomized controlled trial of a practice coaching intervention to increase HIV testing in substance use treatment programs. |
|---|---|
| المؤلفون: | Frimpong JA; Jemima A. Frimpong, New York University Abu Dhabi, PO BOX 129188, Saadiyat Island, Abu Dhabi, UAE., Parish C; Columbia University, Department of Sociomedical Sciences Miami Research Center, 1120 NW 14 Street Room 1030, Miami, FL 33136., Feaster DJ; University of Miami Miller School of Medicine, Department of Public Health Sciences, 1120 NW 14th Street, Room 1059, Miami, FL 33136., Gooden LK; Columbia University, Department of Sociomedical Sciences Miami Research Center, 1120 NW 14 Street Room 1030, Miami, FL 33136., Matheson T; San Francisco Dept of Public Health (SFDPH), 25 Van Ness Avenue; Suite 500, San Francisco, CA 94102., Haynes L; Medical University of South Carolina, 67 President Street, Charleston, SC 29425., Linas BP; Boston Medical Center, Crosstown Building, 801 Massachusetts Ave office 2007, Boston, MA, 02118., Assoumou SA; 801 Massachusetts Ave., Boston, MA, 02118., Tross S; HIV Center For Clinical and Behavioral Studies, NYS Psychiatric Institute, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, N.Y. 10032., Kyle T; University of Miami Miller School of Medicine, Department of Public Health Sciences, 1120 NW 14th Street, Room 1064, Miami, FL 33136., Nelson CM; University of Miami Miller School of Medicine, Department of Public Health Sciences, 1120 NW 14th Street, Room 1064, Miami, FL 33136., Liguori TK; Columbia University, Department of Sociomedical Sciences Miami Research Center, 1120 NW 14 Street Room 1031, Miami, FL 33136., Toussaint O; Columbia University, Department of Sociomedical Sciences Miami Research Center, 1120 NW 14 Street Room 1031, Miami, FL 33136., Siegel K; Columbia University, Department of Sociomedical Sciences, 722 West 168 Street, NY, NY 10032., Annane D; Health Foundation of South Florida, 2 South Biscayne Blvd., Suite 1710, Miami, FL 33131., Metsch LR; Columbia University, Department of Sociomedical Sciences and Columbia School of General Studies, 2970 Broadway, 612 Lewisohn Hall, New York, NY 10026. |
| المصدر: | Research square [Res Sq] 2023 Jun 28. Date of Electronic Publication: 2023 Jun 28. |
| نوع المنشور: | Preprint |
| اللغة: | English |
| بيانات الدورية: | Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE |
| مستخلص: | Background People with substance use disorders are vulnerable to acquiring HIV. Testing is fundamental to diagnosis, treatment, and prevention; however, in the past decade, there has been a decline in the number of substance use disorder (SUD) treatment programs offering on-site HIV testing. Fewer than half of SUDs in the United States offer on-site HIV testing. In addition, nearly a quarter of newly diagnosed cases have AIDS at the time of diagnosis. Lack of testing is one of the main reasons that annual HIV incidences have remained constant over time. Integration of HIV testing with testing for HCV, an infection prevalent among persons vulnerable to HIV infection, and in settings where they receive health services, including opioid treatment programs (OTPs), is of great public health importance. Methods/Design In this 3-arm cluster-RCT of opioid use disorders treatment programs, we test the effect of two evidence-based "practice coaching" (PC) interventions on: the provision and sustained implementation of on-site HIV testing, on-site HIV/HCV testing, and linkage to care. Using the National Survey of Substance Abuse Treatment Services data available from SAMHSA, 51 sites are randomly assigned to one of the three conditions: practice coach facilitated structured conversations around implementing change, with provision of resources and documents to support the implementation of (1) HIV testing only, or (2) HIV/HCV testing, and (3) a control condition that provides a package with information only. We collect quantitative (e,g., HIV and HCV testing at six-month-long intervals) and qualitative site data near the time of randomization, and again approximately 7-12 months after randomization. Discussion Innovative and comprehensive approaches that facilitate and promote the adoption and sustainability of HIV and HCV testing in opioid treatment programs are important for addressing and reducing HIV and HCV infection rates. This study is one of the first to test organizational approaches (practice coaching) to increase HIV and HIV/HCV testing and linkage to care among individuals receiving treatment for opioid use disorder. The study may provide valuable insight and knowledge on the multiple levels of intervention that, if integrated, may better position OTPs to improve and sustain testing practices and improve population health. Trial registration ClinicalTrials.gov: NCT03135886. (02 05 2017). |
| التعليقات: | Update in: Trials. 2023 Sep 26;24(1):609. (PMID: 37749635) |
| References: | Am J Drug Alcohol Abuse. 2013 Jul;39(4):247-51. (PMID: 23841865) Trials. 2016 Mar 03;17(1):117. (PMID: 26936623) J Public Health Manag Pract. 2021 Jul-Aug 01;27(4):393-402. (PMID: 33346582) Drug Alcohol Depend. 2013 Feb 1;128(1-2):90-7. (PMID: 22971593) J Addict Dis. 2011 Apr;30(2):98-109. (PMID: 21491291) Int J Integr Care. 2020 Jun 26;20(2):15. (PMID: 32607102) HIV Med. 2004 May;5(3):174-9. (PMID: 15139984) BMJ. 2013 Jan 08;346:e7586. (PMID: 23303884) Health Serv Res. 2020 Dec;55(6):913-923. (PMID: 33258127) MMWR Morb Mortal Wkly Rep. 2022 Jun 24;71(25):820-824. (PMID: 35737573) AIDS. 2014 Jan 28;28(3):365-76. (PMID: 24670522) Trials. 2022 Apr 23;23(1):341. (PMID: 35461260) J Addict Med. 2022 Mar-Apr 01;16(2):183-191. (PMID: 33973922) Clin Infect Dis. 2012 Jul;55(2):279-90. (PMID: 22491339) Lancet Gastroenterol Hepatol. 2021 Jan;6(1):39-56. (PMID: 33217341) Am J Public Health. 2012 Jun;102(6):1160-7. (PMID: 22515871) Fam Syst Health. 2017 Jun;35(2):227-237. (PMID: 28617023) Drug Alcohol Depend. 2019 Aug 1;201:134-141. (PMID: 31212213) J Infect Dis. 2020 Aug 17;222(6):940-947. (PMID: 32002537) J Subst Abuse Treat. 2016 Apr;63:46-53. (PMID: 26810130) MMWR Morb Mortal Wkly Rep. 2018 Mar 22;68(11):267-272. (PMID: 30897075) |
| معلومات مُعتمدة: | R01 DA043130 United States DA NIDA NIH HHS; UG1 DA013720 United States DA NIDA NIH HHS |
| سلسلة جزيئية: | ClinicalTrials.gov NCT03135886 |
| تواريخ الأحداث: | Date Created: 20230718 Latest Revision: 20231216 |
| رمز التحديث: | 20231216 |
| مُعرف محوري في PubMed: | PMC10350190 |
| DOI: | 10.21203/rs.3.rs-3059783/v1 |
| PMID: | 37461594 |
| قاعدة البيانات: | MEDLINE |
| DOI: | 10.21203/rs.3.rs-3059783/v1 |
|---|